Find uplifting stories about heroes, innovations, and solutions
3 results for "ptsd therapy"
The FDA is accelerating reviews of three psychedelic medications for depression and PTSD, moving promising mental health treatments closer to patients who desperately need them. Millions struggling with treatment-resistant conditions could soon have groundbreaking new options.
The FDA is accelerating approval for psilocybin and MDMA-like therapies to treat depression and PTSD, potentially opening new doors for millions struggling with mental health conditions. Three companies are now on an expedited path to bring these promising treatments to patients who haven't found relief from traditional options.
Scientists in Melbourne discovered a specific brain circuit that explains why common PTSD treatments work brilliantly for some patients but fall short for others. The breakthrough could help millions get therapy that actually matches their brain's needs.